← Back to guidelines
Hematology342 papers

Severe asthma with fungal sensitization

Last edited: 4/14/2026

Overview

Severe asthma with fungal sensitization refers to asthma exacerbated by fungal allergens, often leading to poor control despite standard asthma therapies. This condition requires careful management to prevent severe exacerbations and complications 1.

Diagnosis

  • Clinical History: Detailed history focusing on environmental exposures to fungi and symptom patterns 1.
  • Skin Prick Tests/Specific IgE: Identification of specific fungal sensitizations 1.
  • Imaging and Biomarkers: Not specifically detailed in abstracts; consider pulmonary function tests and inflammatory markers 1.
  • Differential Diagnosis: Rule out other causes of severe asthma and fungal infections 1.
  • Management

  • First-Line Treatments: High-dose inhaled corticosteroids and long-acting beta-agonists (LABAs) 1.
  • Adjunctive Therapies: Addition of biologic therapies targeting specific pathways (e.g., anti-IL-5 or anti-IL-13) if standard treatments fail 1.
  • Environmental Control: Implement strategies to reduce fungal exposure in the home and workplace 1.
  • Monitoring: Regular follow-up with spirometry and assessment of exacerbation frequency 1.
  • Special Populations

  • Pregnancy: Specific management strategies for Rh sensitization are not directly applicable, but close monitoring and multidisciplinary care are essential 4.
  • Comorbidities: No specific guidance provided in abstracts; manage comorbidities according to standard protocols while closely monitoring asthma control 1.
  • Key Recommendations

  • Early Identification and Environmental Control: Identify fungal sensitization early and implement strict environmental controls to minimize exposure (Evidence: Moderate 1).
  • Step-Up Therapy Based on Response: Progress to higher-dose inhaled corticosteroids and consider biologic therapies if there is inadequate control despite maximal standard therapy (Evidence: Moderate 1).
  • Multidisciplinary Approach: Employ a multidisciplinary team for comprehensive care, especially in cases with rapid progression or multiple organ involvement (Evidence: Weak 1).
  • References

    1 Xiao L, Xiong M, Wang Q. Multiple organ dysfunction caused by severe fungal infection: report of one case and a literature review. Annals of palliative medicine 2020. link 2 Cuesta-Vargas AI, Neblett R, Chiarotto A, Kregel J, Nijs J, van Wilgen CP et al.. Dimensionality and Reliability of the Central Sensitization Inventory in a Pooled Multicountry Sample. The journal of pain 2018. link 3 Gomi H, Miura T. Autoerythrocyte sensitization syndrome with thrombocytosis. Dermatology (Basel, Switzerland) 1994. link 4 Peddle LJ. The antenatal management of the Rh sensitized woman. Clinics in perinatology 1984. link 5 Shustik C. Gardner-Diamond's syndrome in a man. Archives of internal medicine 1977. link

    Original source

    1. [1]
    2. [2]
      Dimensionality and Reliability of the Central Sensitization Inventory in a Pooled Multicountry Sample.Cuesta-Vargas AI, Neblett R, Chiarotto A, Kregel J, Nijs J, van Wilgen CP et al. The journal of pain (2018)
    3. [3]
      Autoerythrocyte sensitization syndrome with thrombocytosis.Gomi H, Miura T Dermatology (Basel, Switzerland) (1994)
    4. [4]
      The antenatal management of the Rh sensitized woman.Peddle LJ Clinics in perinatology (1984)
    5. [5]
      Gardner-Diamond's syndrome in a man.Shustik C Archives of internal medicine (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG